117 related articles for article (PubMed ID: 8430625)
1. Design and baseline results of the Scandinavian Simvastatin Survival Study of patients with stable angina and/or previous myocardial infarction.
Am J Cardiol; 1993 Feb; 71(5):393-400. PubMed ID: 8430625
[TBL] [Abstract][Full Text] [Related]
2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
Lancet; 1994 Nov; 344(8934):1383-9. PubMed ID: 7968073
[TBL] [Abstract][Full Text] [Related]
3. Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S).
Kjekshus J; Pedersen TR
Am J Cardiol; 1995 Sep; 76(9):64C-68C. PubMed ID: 7572690
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S).
Pyŏrälä K; Pedersen TR; Kjekshus J; Faergeman O; Olsson AG; Thorgeirsson G
Diabetes Care; 1997 Apr; 20(4):614-20. PubMed ID: 9096989
[TBL] [Abstract][Full Text] [Related]
5. Management of the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) study after the Scandinavian Simvastatin Survival Study (4S).
Tonkin AM
Am J Cardiol; 1995 Sep; 76(9):107C-112C. PubMed ID: 7572678
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study.
Pedersen TR; Berg K; Cook TJ; Faergeman O; Haghfelt T; Kjekshus J; Miettinen T; Musliner TA; Olsson AG; Pyörälä K; Thorgeirsson G; Tobert JA; Wedel H; Wilhelmsen L
Arch Intern Med; 1996 Oct; 156(18):2085-92. PubMed ID: 8862101
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin and simvastatin prevention studies.
Jones PH
Am J Cardiol; 1990 Sep; 66(8):39B-43B. PubMed ID: 2206035
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S).
Miettinen TA; Pyörälä K; Olsson AG; Musliner TA; Cook TJ; Faergeman O; Berg K; Pedersen T; Kjekshus J
Circulation; 1997 Dec; 96(12):4211-8. PubMed ID: 9416884
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.
Wilhelmsen L; Pyörälä K; Wedel H; Cook T; Pedersen T; Kjekshus J
Eur Heart J; 2001 Jul; 22(13):1119-27. PubMed ID: 11428852
[TBL] [Abstract][Full Text] [Related]
10. Coronary artery disease: the Scandinavian Simvastatin Survival Study experience.
Pedersen TR
Am J Cardiol; 1998 Nov; 82(10B):53T-56T. PubMed ID: 9860376
[TBL] [Abstract][Full Text] [Related]
11. Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering.
Pedersen TR; Wilhelmsen L; Faergeman O; Strandberg TE; Thorgeirsson G; Troedsson L; Kristianson J; Berg K; Cook TJ; Haghfelt T; Kjekshus J; Miettinen T; Olsson AG; Pyörälä K; Wedel H
Am J Cardiol; 2000 Aug; 86(3):257-62. PubMed ID: 10922429
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study.
Pedersen TR; Kjekshus J; Berg K; Olsson AG; Wilhelmsen L; Wedel H; Pyörälä K; Miettinen T; Haghfelt T; Faergeman O; Thorgeirsson G; Jönsson B; Schwartz JS
Circulation; 1996 May; 93(10):1796-802. PubMed ID: 8635258
[TBL] [Abstract][Full Text] [Related]
13. Effects of short-term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia.
de Divitiis M; Rubba P; Di Somma S; Liguori V; Galderisi M; Montefusco S; Carreras G; Greco V; Carotenuto A; Iannuzzo G; de Divitiis O
Am J Cardiol; 1996 Oct; 78(7):763-8. PubMed ID: 8857479
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
[TBL] [Abstract][Full Text] [Related]
15. Atherosclerosis and restenosis: reflections on the Lovastatin Restenosis Trial and Scandinavian Simvastatin Survival Study.
Weintraub WS; Pederson JP
Am J Cardiol; 1996 Nov; 78(9):1036-8. PubMed ID: 8916484
[TBL] [Abstract][Full Text] [Related]
16. The effect of simvastatin on progression of coronary artery disease. The Multicenter coronary Intervention Study (CIS).
Bestehorn HP; Rensing UF; Roskamm H; Betz P; Benesch L; Schemeitat K; Blümchen G; Claus J; Mathes P; Kappenberger L; Wieland H; Neiss A
Eur Heart J; 1997 Feb; 18(2):226-34. PubMed ID: 9043838
[TBL] [Abstract][Full Text] [Related]
17. [Data on cholesterol level screening of patients with ischemic heart disease in the light of the Scandinavian Simvastatin Survival Study].
Márk L; Kondacs A; Hanyecz V; Simondán G
Orv Hetil; 1997 Jun; 138(26):1679-82. PubMed ID: 9289681
[TBL] [Abstract][Full Text] [Related]
18. Scandinavian simvastatin study (4S).
White HD
Lancet; 1994 Dec 24-31; 344(8939-8940):1766; author reply 1767-8. PubMed ID: 7997014
[No Abstract] [Full Text] [Related]
19. Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study.
Keech A; Collins R; MacMahon S; Armitage J; Lawson A; Wallendszus K; Fatemian M; Kearney E; Lyon V; Mindell J
Eur Heart J; 1994 Feb; 15(2):255-69. PubMed ID: 8005129
[TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.
Johannesson M; Jönsson B; Kjekshus J; Olsson AG; Pedersen TR; Wedel H
N Engl J Med; 1997 Jan; 336(5):332-6. PubMed ID: 9011785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
